ArticleCancer reports (Hoboken, N.J.)2023

In silico designing and expression of novel recombinant construct containing the variable part of CD44 extracellular domain for prediagnostic breast cancer.

Elaheh Gheybi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.